Multivalent Vaccines Market Data Survey Report 2013-2025

Table of Contents
1 Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Type
1.1.5 Scope of Regions/Countries
1.2 Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 GlaxoSmithKline, plc (U.K.)
3.1.1 Company Information
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.1.4 Recent Development
3.2 Pfizer, Inc. (U.S.)
3.2.1 Company Information
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2.4 Recent Development
3.3 Merck & Co., Inc. (U.S.)
3.3.1 Company Information
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3.4 Recent Development
3.4 Sanofi Pasteur SA (France)
3.4.1 Company Information
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4.4 Recent Development
3.5 Astellas Pharma Inc. (Japan)
3.5.1 Company Information
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5.4 Recent Development
3.6 CSL Limited (Australia)
3.6.1 Company Information
3.6.2 Product & Services
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6.4 Recent Development
3.7 Emergent BioSolutions, Inc. (U.S.)
3.7.1 Company Information
3.7.2 Product & Services
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7.4 Recent Development
3.8 Johnson & Johnson (U.S.)
3.8.1 Company Information
3.8.2 Product & Services
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8.4 Recent Development
3.9 MedImmune, LLC (U.S.)
3.9.1 Company Information
3.9.2 Product & Services
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9.4 Recent Development
3.10 Serum Institute of India Pvt. Ltd. (India)
3.10.1 Company Information
3.10.2 Product & Services
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10.4 Recent Development
3.11 Bavarian Nordic (Denmark)
3.11.1 Company Information
3.11.2 Product & Services
3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11.4 Recent Development
3.12 Mitsubishi Tanabe Pharma Corporation (Japan)
3.12.1 Company Information
3.12.2 Product & Services
3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.12.4 Recent Development
3.13 Daiichi Sankyo (Japan)
3.13.1 Company Information
3.13.2 Product & Services
3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.13.4 Recent Development
3.14 Protein Sciences Corporation (U.S.)
3.14.1 Company Information
3.14.2 Product & Services
3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.15 Panacea Biotec (India)
3.15.1 Company Information
3.15.2 Product & Services
3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 Pediatrics
4.1.1 Overview
4.1.2 Pediatrics Market Size and Forecast
4.2 Adults
4.2.1 Overview
4.2.2 Adults Market Size and Forecast
5 Market by Type
5.By Conjugate Vaccines
5.1 Conjugate Vaccines
5.1.1 Overview
5.1.2 Conjugate Vaccines Market Size and Forecast
5.2 Inactivated and Subunit Vaccines
5.2.1 Overview
5.2.2 Inactivated and Subunit Vaccines Market Size and Forecast
5.3 Live Attenuated Vaccines
5.3.1 Overview
5.3.2 Live Attenuated Vaccines Market Size and Forecast
5.4 Toxoid Vaccines
5.4.1 Overview
5.4.2 Toxoid Vaccines Market Size and Forecast
5.5 Recombinant Vaccines
5.5.1 Overview
5.5.2 Recombinant Vaccines Market Size and Forecast
6 Price Overview
6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type
7 Conclusion